{"id":453989,"date":"2021-03-09T11:24:13","date_gmt":"2021-03-09T16:24:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=453989"},"modified":"2021-03-09T11:24:13","modified_gmt":"2021-03-09T16:24:13","slug":"celularity-to-present-at-h-c-wainwright-global-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/","title":{"rendered":"Celularity to Present at H.C. Wainwright Global Life Sciences Conference"},"content":{"rendered":"<h2>\nCelularity to also participate in a fireside chat and panel discussion with Dr. Scott Gottlieb<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">FLORHAM PARK, N.J., March  09, 2021  (GLOBE NEWSWIRE) &#8212; Celularity Inc. (\u201cCelularity\u201d), a clinical-stage biotechnology company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced that Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity, will present a corporate overview as well as participate in a fireside chat and panel discussion during the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021.<\/p>\n<p align=\"justify\">\n        <strong>Corporate Presentation<br \/><\/strong>A pre-recorded presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on March 9, 2021.<\/p>\n<p align=\"justify\">\n        <strong>Fireside Chat<br \/><\/strong>Topic: Novel Approaches to Allogeneic Cell-Based Immunotherapy: Disruptive Applications in Oncology and Beyond<br \/>Date: March 10, 2021<br \/>Time: 12:00-1:00 p.m. ET<\/p>\n<p align=\"justify\">\n        <strong>Panel on Gene and Cell Therapies <\/strong><br \/>\n        <strong>with Dr. Scott Gottlieb<br \/><\/strong>Date: March 10,\u00a02021<br \/>Time: 3:00-4:30 p.m. ET<br \/>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xON_3GGIphDWjORzcBUMvD13M7hcZW7dTgu9D9OsWZhR219Q9Ed56Ndf6iaTOSJpw1bNVZyD8yWvbcyBASWMzTLPjS_EnX0Y6oCHCnap6atW7veTjSC8yWXhbLBIMAEPKBbZIH3Y0l7BkfC4pPDf_w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Link<\/a><\/p>\n<p align=\"justify\">A video recording of the corporate presentation will be available on the \u201cNewsroom\u201d section of the Celularity website following the conference.<\/p>\n<p>\n        <strong>About Celularity<\/strong><br \/>\n        <br \/>Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placenta-derived allogeneic cell therapies, including genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer infectious and degenerative diseases. Celularity believes that by harnessing the placenta\u2019s unique biology and ready availability, it will be able to develop therapeutic solutions that address a significant unmet global need for effective, accessible, and affordable therapeutics. To learn more visit celularity.com.<\/p>\n<p>\n        <strong>Celularity Investor Contacts:<\/strong><br \/>\n        <br \/>Carlos Ramirez<br \/>Celularity<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s-C6Bsnbr7C1mLbNsVI82_kvaie_JO5ZVKEJRK8zopGeoqq4oAmzz59K-S_qONtF8VZrTW7yKkaIPiExNOWUe3gR4b3xl4EXydKIm_uoX9c_zBq7uO61lWIMUKlly_8c\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">carlos.ramirez@celularity.com<\/a><\/p>\n<p>Alexandra Roy<br \/>Solebury Trout<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dcKDD3UaZdTGj0HStgkPvjopLGLaCI_G2AoILPsK7W8Jm-cqrCR5IIHcAcTgQKdd06BnVNZRRgHmbTowiEx7CwY7i2tmIaRWl8L9TPc6HWg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">aroy@troutgroup.com<\/a>\u00a0\u00a0<\/p>\n<p>\n        <strong>Celularity Media Contact<\/strong><br \/>\n        <br \/>Jason Braco, Ph.D.<br \/>LifeSci Communications<br \/>(646)-751-4361<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vr9uTgeQyim-U7cojwuHXWoVORAF12udmUzwCEEI3uvTcEAJH-Q3A-w7nQfdYakwbRmOXQWhfuTewfOMlMvEDFXNeJe4b1x-3Fk5gIpqd2Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jbraco@lifescicomms.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/aec1894d-564a-44c5-a0ef-7e2225b9b811\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Celularity to also participate in a fireside chat and panel discussion with Dr. Scott Gottlieb FLORHAM PARK, N.J., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Celularity Inc. (\u201cCelularity\u201d), a clinical-stage biotechnology company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced that Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity, will present a corporate overview as well as participate in a fireside chat and panel discussion during the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. Corporate PresentationA pre-recorded presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on March 9, 2021. Fireside ChatTopic: Novel Approaches to Allogeneic Cell-Based Immunotherapy: Disruptive Applications in Oncology and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Celularity to Present at H.C. Wainwright Global Life Sciences Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-453989","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celularity to Present at H.C. Wainwright Global Life Sciences Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celularity to Present at H.C. Wainwright Global Life Sciences Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Celularity to also participate in a fireside chat and panel discussion with Dr. Scott Gottlieb FLORHAM PARK, N.J., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Celularity Inc. (\u201cCelularity\u201d), a clinical-stage biotechnology company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced that Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity, will present a corporate overview as well as participate in a fireside chat and panel discussion during the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. Corporate PresentationA pre-recorded presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on March 9, 2021. Fireside ChatTopic: Novel Approaches to Allogeneic Cell-Based Immunotherapy: Disruptive Applications in Oncology and &hellip; Continue reading &quot;Celularity to Present at H.C. Wainwright Global Life Sciences Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-09T16:24:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Celularity to Present at H.C. Wainwright Global Life Sciences Conference\",\"datePublished\":\"2021-03-09T16:24:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/\"},\"wordCount\":303,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/\",\"name\":\"Celularity to Present at H.C. Wainwright Global Life Sciences Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==\",\"datePublished\":\"2021-03-09T16:24:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celularity to Present at H.C. Wainwright Global Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celularity to Present at H.C. Wainwright Global Life Sciences Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Celularity to Present at H.C. Wainwright Global Life Sciences Conference - Market Newsdesk","og_description":"Celularity to also participate in a fireside chat and panel discussion with Dr. Scott Gottlieb FLORHAM PARK, N.J., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Celularity Inc. (\u201cCelularity\u201d), a clinical-stage biotechnology company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced that Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity, will present a corporate overview as well as participate in a fireside chat and panel discussion during the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. Corporate PresentationA pre-recorded presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on March 9, 2021. Fireside ChatTopic: Novel Approaches to Allogeneic Cell-Based Immunotherapy: Disruptive Applications in Oncology and &hellip; Continue reading \"Celularity to Present at H.C. Wainwright Global Life Sciences Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-09T16:24:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Celularity to Present at H.C. Wainwright Global Life Sciences Conference","datePublished":"2021-03-09T16:24:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/"},"wordCount":303,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/","name":"Celularity to Present at H.C. Wainwright Global Life Sciences Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==","datePublished":"2021-03-09T16:24:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzA1MiM0MDU1NzI5IzUwMDA3ODMxNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celularity-to-present-at-h-c-wainwright-global-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Celularity to Present at H.C. Wainwright Global Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/453989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=453989"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/453989\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=453989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=453989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=453989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}